Workup of the Patient with a Stillbirth

Stillbirth: Prediction, Prevention and Management

Volumn , Issue , 2011, Pages 185-202

  Silver, Robert M ^a   Draper, Michael L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autopsy, clues as to timing of intrauterine death determining fetal growth; Clinical history, perinatal autopsy placental evaluation, karyotype and screening for fmh (as kleihauer betke), recommended in all cases; Fetal maternal hemorrhage (FMH) for 1.5 14 of stillbirths; Identifying cause of stillbirth, sporadic cause recurrence, couples to avoid unnecessary tests; Management of patient with a stillbirth; Optimal evaluation of stillbirth controversial, influenced by medical and nonmedical factors, and cost; Perinatal autopsy fetal autopsy, single most useful diagnostic test in determining cause of fetal loss; Stillbirth, emotional difficulty for families affecting pregnancies in the united states; Whole body x rays, important excluding possible skeletal dysplasias; Workup of patient with a stillbirth

Indexed keywords

EID: 84885781066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398038.ch12     Document Type: Chapter

References (61)

1. Walsh CA, Vallerie AM, Baxi LV. Etiology of stillbirth at term: a 10-year cohort study. J Matern Fetal Neonatal Med 2008;21:493-501.
2. Silver RM. Fetal death. Obstet Gynecol 2007;109: 153-67.
3. Petersson K. Diagnostic evaluation of fetal death with special reference to intrauterine infections. [Dissertation]. Sweden, Stockholm: Department of Clinical Science, Division of Obstetrics and Gynecology, Karolinska Institutet; 2002.
4. Horn LC, Langner A, Stiehl P, et al. Identification of the causes of intrauterine death during 310 consecutive autopsies. Eur J Obstet Gynecol Reprod Biol 2004;113:134-8.
5. Pauli RM, Reiser CA. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals. Am J Med Genet 1994;50:135-53.
6. Lu JR, McCowan L. A comparison of the Perinatal Society of Australia and New Zealand-Perinatal Death Classification system and relevant condition at death stillbirth classification systems. Aust N Z J Obstet Gynecol 2009;49:467-71.
7. Vergani P, Cozzolino S, Pozzi E, et al. Identifying the causes of stillbirth: a comparison of four classification systems. Am J Obstet Gynecol 2008;199:319e1-4.
8. Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005;106:260-7.
9. Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762-7.
10. Frias AE Jr, Luikenaar RA, Sullivan AE, et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004; 104:521-6.
11. Rasmussen S, Irgens LM, Skjaerven R, Melve KK. Prior adverse pregnancy outcome and the risk of stillbirth. Obstet Gynecol 2009;114:1259-70.
12. ACOG Practice Bulletin No. 102: management of stillbirth. Obstet Gynecol 2009;113:748-61.
13. Silver RM, Varner MW, Reddy U, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44.
14. Faye-Petersen OM, Guinn DA, Wenstrom KD. Value of perinatal autopsy. Obstet Gynecol 1999;94: 915-20.
15. Michalski ST, Porter J, Pauli RM. Costs and consequences of comprehensive stillbirth assessment. Am J Obstet Gynecol 2002;186:1027-34.
16. Bonetti LR, Ferrari P, Trani N, et al. The role of fetal autopsy and placental examination in the causes of fetal death: a retrospective study of 132 cases of stillbirths. Arch Gynecol Obstet 2010;Jan 6:Epub.
17. Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG 2001;108:830-4.
18. Bove KE. Practice guidelines for autopsy pathology: the perinatal and pediatric autopsy. Arch Pathol Lab Med 1997;121:368-76.
19. Valdes-Depena M, Huff DS. Perinatal autopsy manual. Washington, DC: Armed Forces Institute of Pathology; 1983.
20. Thayyil S, Cleary JO, Sebire NJ, et al. Post-mortem examination of human fetuses: a comparison of whole-body high-field MRI at 9.4 T with conventional MRI and invasive autopsy. Lancet 2009;374: 467-75.
21. Woodward PJ, Sohaey R, Harris DP, et al. Postmortem fetal MR imaging: comparison with findings at autopsy. AJR Am J Roentgenol 1997;168:41-6.
22. Khong TY. From delivery suite to laboratory: optimizing returns from placental examination in medico-legal defence. Aust N Z J Obstet Gynaecol 1997;37:1-5.
23. Heazell AE, Martindale EA. Can post-mortem examination of the placenta help determine the cause of stillbirth? J Obstet Gynaecol 2009;29:225-8.
24. Parast MM, Crum CP, Boyd TK. Placental histologic criteria for umbilical blood flow restriction in unexplained stillbirth. Hum Pathol 2008;39:948-53.
25. Tantbirojn P, Saleemuddin A, Sirois K, et al. Gross abnormalities of the umbilical cord: related placental histology and clinical significance. Placenta 2009; 30:1083-8.
26. Wapner RJ, Lewis D. Genetics and metabolic causes of stillbirth. Semin Perinatol 2002;26:70-4.
27. Kortweg FJ, Bouman K, Erwich JJ, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for a diagnostic workup. Obstet Gynecol 2008; 111:865-74.
28. Benkhalifa M, Kasakyan S, Clement P, et al. Array comparative genomic hybridization profiling of firsttrimester spontaneous abortions that fail to grow in vitro. Prenat Diagn 2005;25:894-900.
29. ACOG Committee Opinion Number 446. Comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol 2009;114:1161-3.
30. Warren JE, Turok DK, Maxwell TM, et al. Array comparative genomic hybridization for genetic evaluation of fetal loss between 10 and 20 of weeks gestation. Obstet Gynecol 2009;114:1093-102.
31. Raca G, Artzer A, Thorson L, et al. Array-based comparative genomic hybridization (aCGH) in the genetic evaluation of stillbirth. Am J Med Genet A 2009;149A:2437-43.
32. Kalousek DK, Barrett I. Confined placental mosaicism and stillbirth. Pediatr Pathol 1994;14:151-9.
33. Rubod C, Derulle P, Le Gouf F, et al. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol 2007;110:256-60.
34. Laube DW, Schauberger CW. Fetomaternal bleeding as a cause for "unexplained" fetal death. Obstet Gynecol 1982;60:649-51.
35. Marions L, Thomassen P. Six cases of massive fetomaternal bleeding causing intra-uterine fetal death. Acta Obstet Gynecol Scand 1991;70:85-8.
36. Samadi R, Greenspoon JS, Gviazda I, et al. Massive fetomaternal hemorrhage and fetal death: are they predictable? J Perinatol 1999;19:227-9.
37. Pelikan DM, Mesker WE, Scherjon SA, et al. Improvement of the Kleihauer-Betke test by automated detection of fetal erythrocytes in maternal blood. Cytometry B Clin Cytom 2003;54:1-9.
38. Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990;30:344-51.
39. Bowman JM. Controversies in Rh prophylaxis: who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 1985;151:289-94.
40. Stedman CM, Baudin JC, White CA, Cooper ES. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women. Am J Obstet Gynecol 1986;154:1363-9.
41. Ness PM, Baldwin ML, Niebyl JR. Clinical high risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156:154-8.
42. de Almeida V, Bowman JM. Massive fetomaternal hemorrhage: Manitoba experience. Obstet Gynecol 1994;83:323-8.
43. Owen J, Stedman CM, Tucker TL. Comparison of predelivery versus postdelivery Kleihauer-Betke stains in cases of fetal death. Am J Obstet Gynecol 1989;161:663-6.
44. Dziegiel MH, Nielsen LK, Berkowicz A. Detecting fetomaternal hemorrhage by flow cytometry. Curr Opin Hematol 2006;13:490-5.
45. Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv 1997;52:372-80.
46. Lutiger B, Graham K, Einarson T, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology 1991;44:405-14.
47. McClure EM, Goldenberg RL. Infection and stillbirth. Semin Fetal Neonatal Med 2009;14:182-9.
48. Copper RL, Goldenberg RL, DuBard MB, Davis RO. Risk factors for fetal death in white, black, and Hispanic women. Collaborative Group on Preterm Birth Prevention. Obstet Gynecol 1994;84:490-5.
49. Skjöldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, et al. Parvovirus B19 infection: association with third trimester intrauterine fetal death. BJOG 2000; 107:476-80.
50. Centers for Disease Control and Prevention (CDC). Congenital syphilis-United States, 2003-2008. MMWR Morb Mortal Wkly Rep 2010;59:413-17.
51. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008;47:554-66.
52. Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
53. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-96.
54. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-24.
55. Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010;115:14-20.
56. Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010; 115:5-13.
57. Gris JC, Mercier E, Quere I, et al. Low-molecularweight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-9.
58. Warren JE, Simonsen E, Branch DW, et al. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias. Am J Obstet Gynecol 2009;200:281e1-5.
59. Kaandorp SP, Goddijin M, van der Post JAM, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010;362: 1586-96.
60. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 46, September 2003. (Replaces technical bulletin number 222, April 1996). Obstet Gynecol 2003;102:647-58.
61. Silver RM, Varner MV, Reddy U, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44.